Skip to content

Pseudoaneurysm of the Greater Palatine Artery Following Autogenous Connective Tissue Gingival Graft : A Case Series

Pseudoaneurysm of the Greater Palatine Artery Following Autogenous Connective Tissue Gingival Graft : A Case Series

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03454490
Enrollment
10
Registered
2018-03-06
Start date
2018-03-31
Completion date
2018-07-31
Last updated
2018-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pseudoaneurysm

Keywords

Gingival graft, Pseudoaneurysm, Postoperative complication, Gingival recession treatment, Palatine mass, Palatine bleeding

Brief summary

Gingival recession is defined as the apical migration of the gingival margin from the amelocemental junction. This condition may be associated with symptoms such as tooth hypersensitivity, root decay, and cosmetic complaints from patients. Many treatments have been used to treat gingival recession and the gold standard is the autogenous connective tissue gingival graft because of its predictability. This type of gingival graft is performed by harvesting connective tissue from patients' hard palate. Periodontists and general dentists frequently perform these gingival grafts. Occasionally, some patients develop postoperative complications that need to be addressed in an hospital setting. An uncommon but concerning complication of an autogenous connective tissue gingival graft is a donor site pseudoaneurysm of the greater palatine artery. No description of this complication following a gingival graft has been identified in the current literature. One case report mentioned that pseudoaneurysm of the greater palatine artery looks like a pulsatile nodule associated or not with pain on palpation. From the experience of the investigators, patients may consult an hospital setting having a complaint of major oral bleeding. Local hemostatic agents can palliate this type of bleeding, but angiographic embolization is often required. Several cases were treated in the investigators' hospital. Thus, the investigators believe it is relevant to share this experience with the scientific community. The primary objective of this case series is to inform dental professionals of the existence and the management of postoperative pseudoaneurysm of the greater palatine artery following autogenous gingival graft. The secondary objective is to find potential solutions to minimize the incidence of this morbid complication.

Interventions

PROCEDUREPostoperative pseudoaneurysm of the greater palatine artery

Patients had an autogenous connective tissue gingival graft.

Sponsors

Hopital de l'Enfant-Jesus
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Population : Patients having a diagnostic of pseudoaneurysm of the greater palatine artery who had an autogenous connective tissue gingival graft * Intervention : Patients treated with local hemostatic agents or by angiographic embolization * Comparison : None

Exclusion criteria

* Missing data in patients' chart precluding complete data extraction

Design outcomes

Primary

MeasureTime frameDescription
Postoperative oral bleedingOne month following autogenous connective tissue gingival graftComplication following autogenous connective tissue gingival graft

Secondary

MeasureTime frameDescription
Use of local hemostatic agentsSix monthsPalliative method before definitive care
Secondary effects following angiographic interventionSix monthsPostoperative infection, bone or gum necrosis, extrusion of embolization material, loss of tooth, tooth devitalization following angiographic intervention
Number of followups requiredSix monthsSecondary effects following angiographic intervention

Contacts

Primary ContactSimon Jean, DMD
simon.jean.4@ulaval.ca1-418-649-0252
Backup ContactMarianne Bouchard-Asselin, DMD
marianne.bouchard-asselin.1@ulaval.ca1-418-649-0252

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026